Current role
Biotechnology · Healthcare
COO, Board Member
2021-06-30–present
Dr. Lynn Kirkpatrick
Board Member
Ensysce Biosciences, Inc. (ENSC)Equibles does not estimate personal net worth.
Get an email with a short summary when Ensysce Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get ENSC alertsAbout Dr. Lynn Kirkpatrick
Dr. Lynn Kirkpatrick is recorded as COO at Ensysce Biosciences, Inc. (ENSC) since January 1, 2027 and Board Member at Ensysce Biosciences, Inc. (ENSC) since June 30, 2021. Ensysce Biosciences, Inc. reported in an 8-K filed November 4, 2026 that Dr. Lynn Kirkpatrick was appointed Chief Operating Officer, effective January 1, 2027. The proxy statement of Ensysce Biosciences, Inc. reports total compensation of $486,791 for Dr. Lynn Kirkpatrick in fiscal 2025, including a base salary of $453,667. Disclosed compensation is on record for 6 fiscal years. Ensysce Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ensysce Biosciences, Inc. includes Lynn Kirkpatrick (CEO and Board Member), Mr. James Morrisson (CEO), Bob Gower (Chairman and Board Member) and 5 others.
“On October 29, 2026, our Chief Executive Officer, Dr. Lynn Kirkpatrick, age 69, agreed that she would assume the title of Chief Operating Officer of the Company immediately following the Annual Meeting in connection with relinquishing her title of Chief Executive Officer.”
Affiliation history
-
Current
2027-01-01–present
-
Current
2021-06-30–present
-
2021-06-30–2021-12-17
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Ensysce Biosciences, Inc.
- Lynn Kirkpatrick CEO, Board Member
- Mr. James Morrisson CEO
- Bob Gower Chairman, Board Member
- David Humphrey CFO
- Adam Levin Board Member
- Adam S. Levin Board Member
- James Morrison Board Member
- Steve R. Martin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Ensysce Biosciences, Inc. (ENSC) | Chief Executive Officer | $453,667 | $486,791 |
| 2024 | Ensysce Biosciences, Inc. (ENSC) | Chief Executive Officer | $432,042 | $442,392 |
| 2023 | Ensysce Biosciences, Inc. (ENSC) | Chief Executive Officer | $404,875 | $508,575 |
| 2022 | Ensysce Biosciences, Inc. (ENSC) | Chief Executive Officer | $392,500 | $622,609 |
| 2021 | Ensysce Biosciences, Inc. (ENSC) | Chief Executive Officer | $174,149 | $288,149 |
| 2020 | Ensysce Biosciences, Inc. (ENSC) | Chief Executive Officer | $155,868 | $155,868 |